Evidence map›Paper›PMID 37811866›Full record

ArticleJournal of diabetes science and technology2024

NIH Fifth Artificial Pancreas Workshop 2023: Meeting Report: The Fifth Artificial Pancreas Workshop: Enabling Fully Automation, Access, and Adoption.

Rachel E Aaron, Tiffany Tian, Andrea M Yeung, Jingtong Huang, Guillermo A Arreaza-Rubín, Barry H Ginsberg, Tejaswi Kompala, Wei-An Andy Lee, David Kerr, Patricio Colmegna and 4 more

Abstract read
In one paragraph

Article in Journal of diabetes science and technology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Review
  2. Review
  3. Artificial Pancreas: The First 20 Years.Journal of diabetes science and technology · 2025
    Article
  4. Review
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Rachel E AaronDiabetes, Technology Society, Burlingame, CA, USA.ORCID 0009-0005-5120-2264
Tiffany TianDiabetes, Technology Society, Burlingame, CA, USA.ORCID 0009-0003-1417-6445
Andrea M YeungDiabetes, Technology Society, Burlingame, CA, USA.ORCID 0000-0002-5592-453X
Jingtong HuangDiabetes, Technology Society, Burlingame, CA, USA.ORCID 0000-0002-3119-9361
Guillermo A Arreaza-RubínDivision of Diabetes, Endocrinology, and Metabolic Diseases, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD, USA.ORCID 0009-0006-9632-1539
Barry H GinsbergDiabetes Technology Consultants, Arlington, VA, USA.ORCID 0000-0001-5404-826X
Tejaswi KompalaUniversity of Utah, Salt Lake City, UT, USA.ORCID 0000-0002-4492-5035
Wei-An Andy LeeLos Angeles County and University of Southern California Medical Center, Los Angeles, CA, USA.ORCID 0000-0002-2928-7338
David KerrDiabetes, Technology Society, Burlingame, CA, USA.ORCID 0000-0003-1335-1857
Patricio ColmegnaUniversity of Virginia, Charlottesville, VA, USA.ORCID 0000-0001-9074-8634
Carlos E MendezMedical College of Wisconsin, Milwaukee, WI, USA.ORCID 0000-0003-1875-6124
Douglas B MuchmoreKinexum, Harpers Ferry, WV, USA.ORCID 0000-0002-9300-3862
Amisha WalliaNorthwestern University Feinberg School of Medicine, Chicago, IL, USA.ORCID 0000-0002-3183-4062
David C KlonoffDiabetes, Technology Society, Burlingame, CA, USA.ORCID 0000-0001-6394-6862

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The Fifth Artificial Pancreas Workshop: Enabling Fully Automation, Access, and Adoption was held at the National Institutes of Health (NIH) Campus in Bethesda, Maryland on May 1 to 2, 2023. The organizing Committee included representatives of NIH, the US Food and Drug Administration (FDA), Diabetes Technology Society, Juvenile Diabetes Research Foundation (JDRF), and the Leona M. and Harry B. Helmsley Charitable Trust. In previous years, the NIH Division of Diabetes, Endocrinology, and Metabolic Diseases along with other diabetes organizations had organized periodic workshops, and it had been seven years since the NIH hosted the Fourth Artificial Pancreas in July 2016. Since then, significant improvements in insulin delivery have occurred. Several automated insulin delivery (AID) systems are now commercially available. The workshop featured sessions on: (1) Lessons Learned from Recent Advanced Clinical Trials and Real-World Data Analysis, (2) Interoperability, Data Management, Integration of Systems, and Cybersecurity, Challenges and Regulatory Considerations, (3) Adaptation of Systems Through the Lifespan and Special Populations: Are Specific Algorithms Needed, (4) Development of Adaptive Algorithms for Insulin Only and for Multihormonal Systems or Combination with Adjuvant Therapies and Drugs: Clinical Expected Outcomes and Public Health Impact, (5) Novel Artificial Intelligence Strategies to Develop Smarter, More Automated, Personalized Diabetes Management Systems, (6) Novel Sensing Strategies, Hormone Formulations and Delivery to Optimize Close-loop Systems, (7) Special Topic: Clinical and Real-world Viability of IP-IP Systems. "Fully automated closed-loop insulin delivery using the IP route," (8) Round-table Panel: Closed-loop performance: What to Expect and What are the Best Metrics to Assess it, and (9) Round-table Discussion: What is Needed for More Adaptable, Accessible, and Usable Future Generation of Systems? How to Promote Equitable Innovation? This article summarizes the discussions of the Workshop.

Indexed as

Diabetes Mellitus, Type 1Pancreas, ArtificialArtificial IntelligenceAutomationBlood GlucoseHumansHypoglycemic AgentsInsulinInsulin Infusion SystemsInsulin, Regular, HumanBlood GlucoseHypoglycemic AgentsInsulinInsulin, Regular, Humancontinuous glucose monitoringglucosehospitalinpatientinsulinmetrics

Identifiers

PMID37811866
PMCPMC10899838

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.